Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies

Erica Pranzini1, Giovanni Raugei1, Maria Letizia Taddei2

  • 1Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Viale Morgagni 50, 50134 Florence, Italy.

Cancers
|February 15, 2022
PubMed

Insights

Tumor relapse is driven by dormant cancer cells that resist treatment. Understanding their metabolic pathways is key to developing new therapies that target these cells and prevent cancer recurrence.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolism

Background:

  • Tumor relapse, often decades after initial treatment, poses a major challenge in cancer care.
  • This recurrence is frequently linked to dormant cancer cells that are resistant to conventional therapies.
  • These dormant cells can reactivate, leading to tumor regrowth and metastasis.

Purpose of the Study:

  • To explore the molecular mechanisms behind cancer cell dormancy and reactivation.
  • To investigate the critical role of metabolic pathways in maintaining dormant cancer cells.
  • To identify novel therapeutic strategies targeting metabolic adaptations in dormant cells to prevent relapse.

Main Methods:

  • Review of current literature on cancer dormancy, cell cycle regulation, and metabolic adaptations.
  • Analysis of factors influencing dormant cell survival and reactivation, including microenvironmental cues.
  • Exploration of metabolic pathways essential for dormant cancer cell maintenance.

Main Results:

  • Dormant cancer cells exhibit cell cycle arrest and resistance to standard treatments.
  • Metabolic adaptations are crucial for the survival and persistence of dormant cancer cells.
  • Specific microenvironmental factors can trigger the awakening of dormant cells, leading to relapse.

Conclusions:

  • Targeting metabolic pathways in dormant cancer cells offers a promising strategy to prevent tumor recurrence.
  • Further research into the metabolic dependencies of dormant cells is needed to develop effective therapies.
  • Understanding dormancy metabolism can improve patient outcomes and maximize therapeutic benefits.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
711
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K